The invention relates to an orodispersible tablet that is characterized in that said orodispersible tablet comprises burlulipase. The invention further relates to liquid pharmaceutical compositions that contain solutions of such orodispersible tablets in water or other beverages. The invention relates to drugs that contain or consist of such orodispersible tablets or solutions. In particular, the invention relates to such drugs that are suitable for treating digestive problems, in particular exocrine pancreatic insufficiency. In particular, said drugs are suitable for treating exocrine pancreatic insufficiency in patients having mucoviscidosis and for treating exocrine pancreatic insufficiency of patients in pediatrics.
